FCoV-19 VAC (COVID-19 Vaccine for cats and dogs)
Safety & Efficacy
Safety
- We manufacture FCoV-19 VAC through utilizing recombinant protein-based vaccine platform with established safety.
- FCoV-19 VAC is formulated with carefully a selected adjuvant, which has already been verified for its safety in cats and dogs.
- We tested more than 100 cats and dogs to verify the safety.
Efficacy
- Research results showed the significant immunogenicity(neutralizing antibody formation) of vaccinated cats and dogs.
- We sponsored Kansas State University in the United States to conduct efficacy test for ‘FCoV-19 VAC’. The challenge test in cats didn’t show
any virus with a possibility of reinfection in most organs. Also, the symptoms of pneumonia presented were significantly lower than in the
non-vaccinated group, highly reducing the pathogenicity of COVID-19 infection.
